Article details

BioNTech, pas decisiv pentru prealuarea rivalului

Economic RO 04 Dec 2025, 09:02 Source: Profit.ro Archived
This news is archived (not in the current feed). Search similar articles in the archive section.
Read the original article Back to feed

BioNTech, una dintre primele companii care a dezvoltat un vaccin eficient Covid-19, este aproape de achiziționarea rivalului farmaceutic german CureVac, transmite DPA.

Published 4 months ago - updated 3 months ago